Figures

Philadelphia Life Sciences Figures Report Q2 2026

Manufacturing investments advance as demand begins to recover

July 16, 2026 3 Minute Read

Looking for a PDF of this content?

Download

Vacancy remained elevated to start the second quarter, but concrete progress on the region's largest manufacturing commitments and improving leasing activity outside the urban core offered early signs of stabilization. The story of Greater Philadelphia life sciences in 2026 has been one of bifurcation: elevated lab vacancy, offset by large, specialized manufacturing requirements that signal long-term ecosystem confidence. That dynamic continued in Q2, with several deals moving from announcement to execution.